An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Clinical trial NCT05376878 · RECRUITING

Trial details

NCT number: NCT05376878
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma Metastatic Malignant Neoplasm in the Brain

Start date: 2022-12-21
Primary completion: 2027-04-27
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.